1.52
price up icon3.38%   0.04
after-market 시간 외 거래: 1.52
loading
전일 마감가:
$1.48
열려 있는:
$1.47
하루 거래량:
569.57K
Relative Volume:
0.53
시가총액:
$111.48M
수익:
$20.76M
순이익/손실:
$-132.49M
주가수익비율:
-0.5693
EPS:
-2.67
순현금흐름:
$-108.55M
1주 성능:
+6.99%
1개월 성능:
-11.56%
6개월 성능:
-60.36%
1년 성능:
-66.15%
1일 변동 폭
Value
$1.44
$1.53
1주일 범위
Value
$1.395
$1.5991
52주 변동 폭
Value
$1.085
$7.66

C 4 Therapeutics Inc Stock (CCCC) Company Profile

Name
명칭
C 4 Therapeutics Inc
Name
전화
(617) 231-0700
Name
주소
490 ARSENAL WAY, WATERTOWN
Name
직원
110
Name
트위터
Name
다음 수익 날짜
2025-02-24
Name
최신 SEC 제출 서류
Name
CCCC's Discussions on Twitter

CCCC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CCCC
C 4 Therapeutics Inc
1.52 111.48M 20.76M -132.49M -108.55M -2.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.41 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
538.11 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.13 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
546.04 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
240.99 28.51B 3.81B -644.79M -669.77M -6.24

C 4 Therapeutics Inc Stock (CCCC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-19 업그레이드 Wells Fargo Equal Weight → Overweight
2024-11-18 개시 Stephens Equal-Weight
2024-01-29 업그레이드 JP Morgan Underweight → Neutral
2023-12-13 업그레이드 Stifel Hold → Buy
2023-02-24 업그레이드 Credit Suisse Underperform → Neutral
2023-02-24 다운그레이드 JP Morgan Neutral → Underweight
2022-11-04 다운그레이드 JP Morgan Overweight → Neutral
2022-10-11 개시 Morgan Stanley Underweight
2022-04-28 개시 Credit Suisse Underperform
2022-04-11 다운그레이드 BofA Securities Buy → Neutral
2022-03-10 개시 JP Morgan Overweight
2022-02-11 재개 BMO Capital Markets Outperform
2022-02-10 개시 Wells Fargo Equal Weight
2021-11-23 개시 BofA Securities Buy
2021-10-14 개시 SVB Leerink Mkt Perform
2021-09-30 개시 Stifel Hold
2021-06-04 개시 H.C. Wainwright Buy
2021-03-31 개시 BMO Capital Markets Outperform
2020-10-28 개시 UBS Buy
2020-10-27 개시 BMO Capital Markets Outperform
2020-10-27 개시 Jefferies Buy
모두보기

C 4 Therapeutics Inc 주식(CCCC)의 최신 뉴스

pulisher
Jun 18, 2025

C4 Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 17, 2025
pulisher
Jun 17, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 17, 2025
pulisher
Jun 16, 2025

C4 Therapeutics: An Entry Point If There's Ever Going To Be One - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - EyePoint Pharmaceuticals

Jun 16, 2025
pulisher
Jun 13, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 13, 2025
pulisher
Jun 13, 2025

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jun 13, 2025
pulisher
Jun 12, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 12, 2025
pulisher
Jun 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 10, 2025
pulisher
Jun 10, 2025

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jun 10, 2025
pulisher
Jun 09, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 09, 2025
pulisher
Jun 06, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 06, 2025
pulisher
Jun 06, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 06, 2025
pulisher
Jun 06, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 06, 2025
pulisher
Jun 05, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | NTLA Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Jun 05, 2025
pulisher
Jun 05, 2025

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 05, 2025
pulisher
Jun 03, 2025

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Biotech Startup Xilio Awards $194K Worth of Stock Options Under Nasdaq Compliance Plan - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 03, 2025
pulisher
Jun 03, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 03, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Jun 02, 2025
pulisher
Jun 02, 2025

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Jun 02, 2025
pulisher
Jun 02, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 02, 2025
pulisher
May 30, 2025

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - TradingView

May 30, 2025
pulisher
May 22, 2025

Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025 - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

C4 Therapeutics patents new B-Raf V600E mutant degradation inducers - BioWorld MedTech

May 21, 2025
pulisher
May 16, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Eyepoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - EyePoint Pharmaceuticals

May 16, 2025
pulisher
May 15, 2025

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - TradingView

May 15, 2025
pulisher
May 12, 2025

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bluefield Daily Telegraph

May 12, 2025
pulisher
May 12, 2025

Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

May 12, 2025
pulisher
May 08, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

C4 Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 08, 2025

Cemsidomide Combo May Produce Responses in Multiple Myeloma - CancerNetwork

May 08, 2025

C 4 Therapeutics Inc (CCCC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

C 4 Therapeutics Inc 주식 (CCCC) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Boyle Scott N
Chief Business Officer
Feb 14 '25
Sale
3.15
490
1,544
110,842
$20.52
price up icon 0.91%
$35.59
price down icon 2.21%
$22.61
price down icon 7.84%
$96.95
price down icon 1.06%
$110.05
price up icon 0.06%
biotechnology ONC
$240.99
price down icon 1.69%
자본화:     |  볼륨(24시간):